Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.43 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 5/20 | 0.41 |
| ▸ | PPARD | Q03181 | 5/20 | 0.41 |
| ▸ | PPARA | Q07869 | 5/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TLR2 | O60603 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11122393 | 0.93 | LMNA (0.50) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL6088956 | 0.93 | LMNA (0.48) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL11662325 | 0.91 | TSHR (0.52) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL27955655 | 0.91 | TSHR (0.52) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL10533707 | 0.91 | TSHR (0.52) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL17480707 | 0.91 | TSHR (0.52) | LMNASLC22A6TSHRNFKB1PMP22 | |
| Succinic Acid SCHEMBL30420635 | 0.91 | LMNA (0.46) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL7000281 | 0.85 | CYP1A2 (0.54) | LMNACYP1A2FOLH1KDM4ATET2 | |
| SCHEMBL2797202 | 0.85 | LMNA (0.56) | LMNASLC22A6CYP1A2FOLH1TSHR | |
| SCHEMBL12851375 | 0.85 | GPR84 (0.41) | CYP1A2TSHRPPARDGPR84TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107922676-A | Carboxylic acid-modified nitrile copolymer latex, method for producing the same, latex composition for dip molding, and dip molded article | 株式会社LG化学 | 2018-04-17 | — | — | CN | claimed |
| US-20240150798-A1 | MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE | GENOMATICA INC (US) | 2024-05-09 | — | — | US | disclosed |
| US-20230416698-A1 | ALDEHYDE DEHYDROGENASE VARIANTS AND METHODS OF USING SAME | AGAIN BIO APS (DK) | 2023-12-28 | — | — | US | disclosed |
| US-11814664-B2 | Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate | GENOMATICA, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-20230332194-A1 | MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING ADIPATE, 6-AMINOCAPROATE, HEXAMETHYLENEDIAMINE OR CAPROLACTAM RELATED THERETO | GENOMATICA INC (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230287464-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BUTADIENE USING ACETYL-COA | GENOMATICA INC (US) | 2023-09-14 | — | — | US | disclosed |
| US-11753663-B2 | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing adipate, 6-aminocaproate, hexamethylenediamine or caprolactam related thereto | GENOMATICA, INC. (US) | 2023-09-12 | — | — | US | disclosed |
| US-11572564-B2 | Microorganisms for producing 1,4-butanediol and methods related thereto | GENOMATICA, INC. (US) | 2023-02-07 | — | — | US | disclosed |
| US-20220220511-A1 | MICROORGANISMS AND METHODS FOR PRODUCING BUTADIENE AND RELATED COMPOUNDS BY FORMATE ASSIMILATION | GENOMATICA INC (US) | 2022-07-14 | — | — | US | disclosed |
| US-11371063-B2 | Microorganisms and methods for the production of butadiene using acetyl-coA | GENOMATICA, INC. (US) | 2022-06-28 | — | — | US | disclosed |
| US-7851188-B2 | producing isobutanol by the fermentive growth of a recombinant bacteria expressing a isobutanol biosynthetic pathway | BUTAMAX(TM) ADVANCED BIOFUELS LLC (US) | 2010-12-14 | — | — | US | disclosed |
| US-20100304453-A1 | MICROORGANISMS AND METHODS FOR CONVERSION OF SYNGAS AND OTHER CARBON SOURCES TO USEFUL PRODUCTS | GENOMATICA, INC. (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100120710-A1 | Branched alpha-glucan, alpha-glucosyltransferase which forms the glucan, their preparation and uses | NAGASE VIITA CO., LTD. (JP) | 2010-05-13 | — | — | US | disclosed |
| EP-2151500-A1 | BRANCHED -GLUCAN, -GLUCOSYLTRANSFERASE PRODUCING THE SAME, METHOD FOR PRODUCING THE SAME AND USE THEREOF | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) | 2010-02-10 | — | — | EP | disclosed |
| US-20080274524-A1 | METHOD FOR THE PRODUCTION OF 1-BUTANOL | GEVO, INC. | 2008-11-06 | — | — | US | disclosed |
| US-20080274526-A1 | METHOD FOR THE PRODUCTION OF ISOBUTANOL | BUTAMAX ADVANCED BIOFUELS LLC | 2008-11-06 | — | — | US | disclosed |
| US-20080182308-A1 | A recombinant microbial host cell having a heterologous DNA encoding polypeptides as oxidoreductases to catalyze a biosynthetic pathway beginning with acetyl-CoA to produce efficiently 1-butanol as the only product; industrial microbiology; pollution control; fuel additives; food processing | GEVO, INC. | 2008-07-31 | — | — | US | disclosed |
| US-20070092957-A1 | producing isobutanol by the fermentive growth of a recombinant bacteria expressing a isobutanol biosynthetic pathway | GEVO, INC. | 2007-04-26 | — | — | US | disclosed |
| CN-1036275-C | N-methylate bis-4-piperidyl phosphite | CIBA GEIGY AG (CH) | 1997-10-29 | — | — | CN | disclosed |
| CN-1069274-A | Methylated pair-4-piperidyl phosphite of N- | CIBA GEIGY AG (CH) | 1993-02-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150798-A1 | MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE | ACACB, GRHPR, HSD17B10 | LMNA 2983/4885SLC22A6 4007/4885CYP1A2 1014/4885 |
| US-11814664-B2 | Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate | ACACB, GRHPR, HSD17B10 | LMNA 2983/4885SLC22A6 4007/4885CYP1A2 1014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.